MyAverix Finance
ST · Healthcare
Simris Alg AB (publ) (SIMRIS-B)
Biotechnology
Simris Alg AB (publ) (SIMRIS-B) is listed on ST in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $108.25M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SIMRIS-B
Simris Alg AB (publ) (SIMRIS-B) — FAQ
What is Simris Alg AB (publ)'s market cap?
Simris Alg AB (publ) (SIMRIS-B) has a reported market cap of $108.25M (data as of 2026-05-24).
What is SIMRIS-B's P/E ratio?
The price-to-earnings (P/E) ratio for Simris Alg AB (publ) (SIMRIS-B) is 25.00 (data as of 2026-05-24).
Does Simris Alg AB (publ) pay a dividend?
Dividend yield is not available in the current snapshot for Simris Alg AB (publ) (SIMRIS-B). Check the MyAverix Finance app for the latest dividend data.
What sector is Simris Alg AB (publ) in?
Simris Alg AB (publ) (SIMRIS-B) is classified in the Healthcare sector (Biotechnology industry).
What exchange is SIMRIS-B listed on?
SIMRIS-B is listed on ST.
What is Simris Alg AB (publ)'s net margin?
Simris Alg AB (publ) (SIMRIS-B) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.